Hermioni L Amonoo1, Christina N Massey2, Melanie E Freedman2, Areej El-Jawahri3, Halyna L Vitagliano4, William F Pirl4, Jeff C Huffman5. 1. Dana Farber Cancer Institute, Department of Psychosocial Oncology, Brookline, MA; Brigham and Women's Hospital, Boston, MA; Department of Psychiatry, Harvard Medical School, Boston, MA. Electronic address: Hermioni_lokko@dfci.harard.edu. 2. Massachusetts General Hospital, Department of Psychiatry, Boston, MA. 3. Massachusetts General Hospital, Department of Hematology/Oncology, Boston, MA. 4. Dana Farber Cancer Institute, Department of Psychosocial Oncology, Brookline, MA; Department of Psychiatry, Harvard Medical School, Boston, MA. 5. Department of Psychiatry, Harvard Medical School, Boston, MA; Massachusetts General Hospital, Department of Psychiatry, Boston, MA.
Abstract
BACKGROUND: In recent decades, advances in transplantation medicine, and improved posttransplant care have reduced morbidity and mortality from hematopoietic stem cell transplantations (HSCTs). However, patients undergoing HSCT report a high prevalence of psychological distress, which can negatively impact recovery, function, and health outcomes, including mortality and higher risk of graft vs. host disease. Appropriate assessment and management of these psychological symptoms lead to better engagement with treatment and a variety of superior health outcomes. OBJECTIVE: We provide a narrative review of the psychological challenges that accompany HSCT and suggest management approaches to equip psychiatric consultants involved in the care of this patient population. METHODS: We reviewed published work in PubMed, PsycInfo, and Scopus electronic databases on the common psychological challenges in HSCT, their vulnerability factors, as well as practical interventions for managing these challenges. RESULTS: We outline the phases of the HSCT hospitalization and discuss common psychological challenges, such as depression, delirium, and post-traumatic stress reactions that accompany HSCT. We suggest an approach to psychiatric consults during the HSCT hospitalization and discuss practical interventions for managing psychological challenges in this population. CONCLUSIONS: Though pharmacological and behavioral interventions have been successfully used to treat psychosocial challenges in HSCT, further research is needed to understand the optimal psychiatric assessment tools, treatment strategies, and the long-term psychiatric care needed to address psychiatric comorbidities in this growing patient population.
BACKGROUND: In recent decades, advances in transplantation medicine, and improved posttransplant care have reduced morbidity and mortality from hematopoietic stem cell transplantations (HSCTs). However, patients undergoing HSCT report a high prevalence of psychological distress, which can negatively impact recovery, function, and health outcomes, including mortality and higher risk of graft vs. host disease. Appropriate assessment and management of these psychological symptoms lead to better engagement with treatment and a variety of superior health outcomes. OBJECTIVE: We provide a narrative review of the psychological challenges that accompany HSCT and suggest management approaches to equip psychiatric consultants involved in the care of this patient population. METHODS: We reviewed published work in PubMed, PsycInfo, and Scopus electronic databases on the common psychological challenges in HSCT, their vulnerability factors, as well as practical interventions for managing these challenges. RESULTS: We outline the phases of the HSCT hospitalization and discuss common psychological challenges, such as depression, delirium, and post-traumatic stress reactions that accompany HSCT. We suggest an approach to psychiatric consults during the HSCT hospitalization and discuss practical interventions for managing psychological challenges in this population. CONCLUSIONS: Though pharmacological and behavioral interventions have been successfully used to treat psychosocial challenges in HSCT, further research is needed to understand the optimal psychiatric assessment tools, treatment strategies, and the long-term psychiatric care needed to address psychiatric comorbidities in this growing patient population.
Authors: Lisa M Wu; Jane Austin; Jada G Hamilton; Heiddis Valdimarsdottir; Luis Isola; Scott Rowley; Rachel Warbet; Gary Winkel; William H Redd; Christine Rini Journal: Psychooncology Date: 2011-07-08 Impact factor: 3.894
Authors: T M Graff; A K Singavi; W Schmidt; D Eastwood; W R Drobyski; M Horowitz; J Palmer; M Pasquini; D J Rizzo; W Saber; P Hari; T S Fenske Journal: Bone Marrow Transplant Date: 2015-04-13 Impact factor: 5.483
Authors: R P McQuellon; G B Russell; T D Rambo; B L Craven; J Radford; J J Perry; J Cruz; D D Hurd Journal: Bone Marrow Transplant Date: 1998-03 Impact factor: 5.483
Authors: Kelly Kenzik; I-Chan Huang; J Douglas Rizzo; Elizabeth Shenkman; John Wingard Journal: Support Care Cancer Date: 2014-09-06 Impact factor: 3.603
Authors: S E Ghazikhanian; C S Dorfman; T J Somers; M L O'Sullivan; H M Fisher; S N Edmond; A A Wren; S A Kelleher; K A Rowe Nichols; N Chao; R A Shelby Journal: Bone Marrow Transplant Date: 2016-12-12 Impact factor: 5.483
Authors: Hermioni L Amonoo; Lauren E Harnedy; Emma C Deary; Lara Traeger; Lydia A Brown; Elizabeth P Daskalakis; Corey Cutler; Amar H Kelkar; Rachael Rosales; Lauren Goldschen; William F Pirl; Emily H Feig; Anna Revette; Stephanie J Lee; Jeff C Huffman; Areej El-Jawahri Journal: Bone Marrow Transplant Date: 2022-05-19 Impact factor: 5.174
Authors: Steffen T Simon; Anne Pralong; Michael Hallek; Christoph Scheid; Udo Holtick; Marco Herling Journal: Ann Hematol Date: 2021-05-06 Impact factor: 3.673
Authors: Julia Spierings; Carolijn Jm de Bresser; Femke Cc van Rhijn-Brouwer; Arwen Pieterse; Madelon C Vonk; Alexandre E Voskuyl; Jeska K de Vries-Bouwstra; Jacob M van Laar; Marijke C Kars Journal: J Scleroderma Relat Disord Date: 2020-05-28
Authors: Christine Rini; Margaret Waltz; Katrin Bovbjerg; David Farrell; Betina Yanez; Anthony Chicaiza; Madison L Hartstein; Rahma Omar; Rebecca Thompson; Scott D Rowley; Annette L Stanton; Heiddis Valdimarsdottir; Jane Austin; Alyssa N Van Denburg; Kristi D Graves Journal: Psychooncology Date: 2022-07-07 Impact factor: 3.955